nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenofibrate—CYP2C9—Bexarotene—hematologic cancer	0.0377	0.0668	CbGbCtD
Fenofibrate—CYP2C8—Bortezomib—hematologic cancer	0.0331	0.0587	CbGbCtD
Fenofibrate—CYP2C9—Idarubicin—hematologic cancer	0.0312	0.0554	CbGbCtD
Fenofibrate—CYP2C8—Ifosfamide—hematologic cancer	0.0254	0.045	CbGbCtD
Fenofibrate—CYP2C9—Bortezomib—hematologic cancer	0.0231	0.041	CbGbCtD
Fenofibrate—CYP2C8—Nilotinib—hematologic cancer	0.0221	0.0391	CbGbCtD
Fenofibrate—CYP3A4—Bexarotene—hematologic cancer	0.0219	0.0389	CbGbCtD
Fenofibrate—CYP3A4—Lomustine—hematologic cancer	0.0204	0.0361	CbGbCtD
Fenofibrate—CYP3A4—Busulfan—hematologic cancer	0.0204	0.0361	CbGbCtD
Fenofibrate—CYP2C9—Thalidomide—hematologic cancer	0.0201	0.0357	CbGbCtD
Fenofibrate—CYP2C9—Teniposide—hematologic cancer	0.0192	0.034	CbGbCtD
Fenofibrate—CYP3A4—Thiotepa—hematologic cancer	0.0182	0.0322	CbGbCtD
Fenofibrate—CYP2C9—Ifosfamide—hematologic cancer	0.0177	0.0314	CbGbCtD
Fenofibrate—CYP2C9—Imatinib—hematologic cancer	0.0169	0.03	CbGbCtD
Fenofibrate—CYP2C9—Nilotinib—hematologic cancer	0.0154	0.0273	CbGbCtD
Fenofibrate—CYP3A4—Methoxsalen—hematologic cancer	0.0141	0.025	CbGbCtD
Fenofibrate—CYP3A4—Bortezomib—hematologic cancer	0.0134	0.0238	CbGbCtD
Fenofibrate—CYP3A4—Daunorubicin—hematologic cancer	0.0129	0.0228	CbGbCtD
Fenofibrate—CYP2C8—Etoposide—hematologic cancer	0.0121	0.0215	CbGbCtD
Fenofibrate—CYP3A4—Cytarabine—hematologic cancer	0.0113	0.0201	CbGbCtD
Fenofibrate—CYP3A4—Teniposide—hematologic cancer	0.0112	0.0198	CbGbCtD
Fenofibrate—CYP3A4—Ifosfamide—hematologic cancer	0.0103	0.0183	CbGbCtD
Fenofibrate—CYP2C8—Dexamethasone—hematologic cancer	0.00999	0.0177	CbGbCtD
Fenofibrate—CYP3A4—Imatinib—hematologic cancer	0.00985	0.0174	CbGbCtD
Fenofibrate—CYP3A4—Ruxolitinib—hematologic cancer	0.00927	0.0164	CbGbCtD
Fenofibrate—CYP3A4—Nilotinib—hematologic cancer	0.00895	0.0159	CbGbCtD
Fenofibrate—CYP3A4—Vinorelbine—hematologic cancer	0.00887	0.0157	CbGbCtD
Fenofibrate—CYP2C9—Cisplatin—hematologic cancer	0.00862	0.0153	CbGbCtD
Fenofibrate—CYP3A4—Triamcinolone—hematologic cancer	0.00812	0.0144	CbGbCtD
Fenofibrate—CYP3A4—Dasatinib—hematologic cancer	0.00791	0.014	CbGbCtD
Fenofibrate—CYP3A4—Mitoxantrone—hematologic cancer	0.00781	0.0138	CbGbCtD
Fenofibrate—CYP2C9—Dexamethasone—hematologic cancer	0.00697	0.0123	CbGbCtD
Fenofibrate—CYP3A4—Betamethasone—hematologic cancer	0.00696	0.0123	CbGbCtD
Fenofibrate—CYP3A4—Prednisolone—hematologic cancer	0.00687	0.0122	CbGbCtD
Fenofibrate—CYP3A4—Prednisone—hematologic cancer	0.00649	0.0115	CbGbCtD
Fenofibrate—CYP3A4—Irinotecan—hematologic cancer	0.00615	0.0109	CbGbCtD
Fenofibrate—CYP3A4—Vinblastine—hematologic cancer	0.00547	0.00969	CbGbCtD
Fenofibrate—CYP3A4—Vincristine—hematologic cancer	0.00538	0.00953	CbGbCtD
Fenofibrate—CYP3A4—Etoposide—hematologic cancer	0.00493	0.00873	CbGbCtD
Fenofibrate—CYP3A4—Dexamethasone—hematologic cancer	0.00405	0.00718	CbGbCtD
Fenofibrate—CYP3A4—Doxorubicin—hematologic cancer	0.00336	0.00595	CbGbCtD
Fenofibrate—PPARA—hematopoietic system—hematologic cancer	0.0015	0.203	CbGeAlD
Fenofibrate—PPARA—blood—hematologic cancer	0.000992	0.134	CbGeAlD
Fenofibrate—PPARA—lung—hematologic cancer	0.000869	0.118	CbGeAlD
Fenofibrate—Indomethacin—ABCC3—hematologic cancer	0.000848	0.439	CrCbGaD
Fenofibrate—PPARA—testis—hematologic cancer	0.00082	0.111	CbGeAlD
Fenofibrate—Indomethacin—UGT1A1—hematologic cancer	0.000733	0.379	CrCbGaD
Fenofibrate—PPARA—lymph node—hematologic cancer	0.000595	0.0805	CbGeAlD
Fenofibrate—CYP2C8—hematopoietic system—hematologic cancer	0.000543	0.0735	CbGeAlD
Fenofibrate—CYP2C9—hematopoietic system—hematologic cancer	0.000482	0.0653	CbGeAlD
Fenofibrate—CYP3A4—hematopoietic system—hematologic cancer	0.000368	0.0498	CbGeAlD
Fenofibrate—CYP2C8—blood—hematologic cancer	0.000359	0.0487	CbGeAlD
Fenofibrate—CYP2C9—blood—hematologic cancer	0.000319	0.0432	CbGeAlD
Fenofibrate—CYP2C8—testis—hematologic cancer	0.000297	0.0403	CbGeAlD
Fenofibrate—CYP3A4—blood—hematologic cancer	0.000243	0.033	CbGeAlD
Fenofibrate—Indomethacin—ALB—hematologic cancer	0.00018	0.093	CrCbGaD
Fenofibrate—Indomethacin—ABCB1—hematologic cancer	0.000171	0.0887	CrCbGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.93e-05	0.000306	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CD44—hematologic cancer	2.91e-05	0.000304	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—NQO1—hematologic cancer	2.91e-05	0.000304	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—FTCD—hematologic cancer	2.87e-05	0.0003	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GMPS—hematologic cancer	2.87e-05	0.0003	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PHYH—hematologic cancer	2.87e-05	0.0003	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—NCOR1—hematologic cancer	2.87e-05	0.0003	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.85e-05	0.000298	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	2.84e-05	0.000297	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—DCK—hematologic cancer	2.82e-05	0.000295	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—B3GAT1—hematologic cancer	2.82e-05	0.000295	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ASNS—hematologic cancer	2.82e-05	0.000295	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.76e-05	0.000288	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CYCS—hematologic cancer	2.76e-05	0.000288	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—HSP90AA1—hematologic cancer	2.74e-05	0.000286	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	2.71e-05	0.000283	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	2.68e-05	0.00028	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—HDC—hematologic cancer	2.68e-05	0.000279	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—NR3C1—hematologic cancer	2.66e-05	0.000277	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—EP300—hematologic cancer	2.63e-05	0.000275	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—SMPD3—hematologic cancer	2.63e-05	0.000274	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	2.62e-05	0.000274	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—SRC—hematologic cancer	2.56e-05	0.000267	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.49e-05	0.00026	CbGpPWpGaD
Fenofibrate—Pain—Betamethasone—hematologic cancer	2.49e-05	7.54e-05	CcSEcCtD
Fenofibrate—Pain—Dexamethasone—hematologic cancer	2.49e-05	7.54e-05	CcSEcCtD
Fenofibrate—Visual impairment—Doxorubicin—hematologic cancer	2.49e-05	7.54e-05	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—VEGFA—hematologic cancer	2.49e-05	0.00026	CbGpPWpGaD
Fenofibrate—Nervous system disorder—Prednisone—hematologic cancer	2.49e-05	7.53e-05	CcSEcCtD
Fenofibrate—Tachycardia—Prednisone—hematologic cancer	2.48e-05	7.5e-05	CcSEcCtD
Fenofibrate—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	2.47e-05	0.000258	CbGpPWpGaD
Fenofibrate—Alopecia—Epirubicin—hematologic cancer	2.47e-05	7.47e-05	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—STAT3—hematologic cancer	2.47e-05	0.000258	CbGpPWpGaD
Fenofibrate—Skin disorder—Prednisone—hematologic cancer	2.47e-05	7.46e-05	CcSEcCtD
Fenofibrate—Nausea—Gemcitabine—hematologic cancer	2.46e-05	7.46e-05	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.46e-05	0.000257	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—NRAS—hematologic cancer	2.46e-05	0.000257	CbGpPWpGaD
Fenofibrate—Vomiting—Cisplatin—hematologic cancer	2.46e-05	7.44e-05	CcSEcCtD
Fenofibrate—Hyperhidrosis—Prednisone—hematologic cancer	2.45e-05	7.43e-05	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.45e-05	0.000256	CbGpPWpGaD
Fenofibrate—Mental disorder—Epirubicin—hematologic cancer	2.45e-05	7.41e-05	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism—CDA—hematologic cancer	2.45e-05	0.000255	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	2.44e-05	0.000255	CbGpPWpGaD
Fenofibrate—Rash—Cisplatin—hematologic cancer	2.44e-05	7.38e-05	CcSEcCtD
Fenofibrate—PPARA—Generic Transcription Pathway—MYC—hematologic cancer	2.44e-05	0.000254	CbGpPWpGaD
Fenofibrate—Dermatitis—Cisplatin—hematologic cancer	2.44e-05	7.37e-05	CcSEcCtD
Fenofibrate—Malnutrition—Epirubicin—hematologic cancer	2.43e-05	7.36e-05	CcSEcCtD
Fenofibrate—Erythema—Epirubicin—hematologic cancer	2.43e-05	7.36e-05	CcSEcCtD
Fenofibrate—PPARA—Metabolism—GSTP1—hematologic cancer	2.43e-05	0.000254	CbGpPWpGaD
Fenofibrate—Diarrhoea—Etoposide—hematologic cancer	2.42e-05	7.33e-05	CcSEcCtD
Fenofibrate—Anorexia—Prednisone—hematologic cancer	2.42e-05	7.32e-05	CcSEcCtD
Fenofibrate—Eye disorder—Doxorubicin—hematologic cancer	2.42e-05	7.31e-05	CcSEcCtD
Fenofibrate—Ill-defined disorder—Methotrexate—hematologic cancer	2.41e-05	7.3e-05	CcSEcCtD
Fenofibrate—Anaemia—Methotrexate—hematologic cancer	2.4e-05	7.27e-05	CcSEcCtD
Fenofibrate—Feeling abnormal—Dexamethasone—hematologic cancer	2.4e-05	7.27e-05	CcSEcCtD
Fenofibrate—Feeling abnormal—Betamethasone—hematologic cancer	2.4e-05	7.27e-05	CcSEcCtD
Fenofibrate—Cardiac disorder—Doxorubicin—hematologic cancer	2.4e-05	7.26e-05	CcSEcCtD
Fenofibrate—Flatulence—Epirubicin—hematologic cancer	2.4e-05	7.25e-05	CcSEcCtD
Fenofibrate—Tension—Epirubicin—hematologic cancer	2.39e-05	7.22e-05	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.39e-05	0.000249	CbGpPWpGaD
Fenofibrate—Gastrointestinal pain—Betamethasone—hematologic cancer	2.38e-05	7.21e-05	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.38e-05	7.21e-05	CcSEcCtD
Fenofibrate—Hypersensitivity—Triamcinolone—hematologic cancer	2.37e-05	7.16e-05	CcSEcCtD
Fenofibrate—Nervousness—Epirubicin—hematologic cancer	2.36e-05	7.15e-05	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—MAPK3—hematologic cancer	2.36e-05	0.000246	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PC—hematologic cancer	2.36e-05	0.000246	CbGpPWpGaD
Fenofibrate—Back pain—Epirubicin—hematologic cancer	2.35e-05	7.12e-05	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.35e-05	0.000245	CbGpPWpGaD
Fenofibrate—Angiopathy—Doxorubicin—hematologic cancer	2.35e-05	7.1e-05	CcSEcCtD
Fenofibrate—Malaise—Methotrexate—hematologic cancer	2.34e-05	7.09e-05	CcSEcCtD
Fenofibrate—Dizziness—Etoposide—hematologic cancer	2.34e-05	7.09e-05	CcSEcCtD
Fenofibrate—Muscle spasms—Epirubicin—hematologic cancer	2.34e-05	7.08e-05	CcSEcCtD
Fenofibrate—Vertigo—Methotrexate—hematologic cancer	2.34e-05	7.07e-05	CcSEcCtD
Fenofibrate—Mediastinal disorder—Doxorubicin—hematologic cancer	2.33e-05	7.05e-05	CcSEcCtD
Fenofibrate—Leukopenia—Methotrexate—hematologic cancer	2.33e-05	7.04e-05	CcSEcCtD
Fenofibrate—Urticaria—Dexamethasone—hematologic cancer	2.32e-05	7.01e-05	CcSEcCtD
Fenofibrate—Urticaria—Betamethasone—hematologic cancer	2.32e-05	7.01e-05	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.31e-05	7e-05	CcSEcCtD
Fenofibrate—Dizziness—Prednisolone—hematologic cancer	2.31e-05	6.99e-05	CcSEcCtD
Fenofibrate—Arrhythmia—Doxorubicin—hematologic cancer	2.31e-05	6.99e-05	CcSEcCtD
Fenofibrate—Asthenia—Triamcinolone—hematologic cancer	2.31e-05	6.98e-05	CcSEcCtD
Fenofibrate—Abdominal pain—Betamethasone—hematologic cancer	2.31e-05	6.97e-05	CcSEcCtD
Fenofibrate—Abdominal pain—Dexamethasone—hematologic cancer	2.31e-05	6.97e-05	CcSEcCtD
Fenofibrate—Body temperature increased—Betamethasone—hematologic cancer	2.31e-05	6.97e-05	CcSEcCtD
Fenofibrate—Body temperature increased—Dexamethasone—hematologic cancer	2.31e-05	6.97e-05	CcSEcCtD
Fenofibrate—PPARA—Metabolism—ABCB1—hematologic cancer	2.3e-05	0.00024	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—MAPK14—hematologic cancer	2.3e-05	0.00024	CbGpPWpGaD
Fenofibrate—Nausea—Cisplatin—hematologic cancer	2.3e-05	6.95e-05	CcSEcCtD
Fenofibrate—Insomnia—Prednisone—hematologic cancer	2.3e-05	6.95e-05	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism—B3GAT1—hematologic cancer	2.3e-05	0.00024	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—DCK—hematologic cancer	2.3e-05	0.00024	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ASNS—hematologic cancer	2.3e-05	0.00024	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—TGFB1—hematologic cancer	2.29e-05	0.000239	CbGpPWpGaD
Fenofibrate—Alopecia—Doxorubicin—hematologic cancer	2.29e-05	6.91e-05	CcSEcCtD
Fenofibrate—Paraesthesia—Prednisone—hematologic cancer	2.28e-05	6.9e-05	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism—GBA—hematologic cancer	2.27e-05	0.000238	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—SLC35B2—hematologic cancer	2.27e-05	0.000238	CbGpPWpGaD
Fenofibrate—Pruritus—Triamcinolone—hematologic cancer	2.27e-05	6.88e-05	CcSEcCtD
Fenofibrate—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	2.27e-05	0.000237	CbGpPWpGaD
Fenofibrate—Cough—Methotrexate—hematologic cancer	2.27e-05	6.86e-05	CcSEcCtD
Fenofibrate—Mental disorder—Doxorubicin—hematologic cancer	2.27e-05	6.86e-05	CcSEcCtD
Fenofibrate—Ill-defined disorder—Epirubicin—hematologic cancer	2.26e-05	6.83e-05	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—ESR1—hematologic cancer	2.26e-05	0.000235	CbGpPWpGaD
Fenofibrate—Vomiting—Etoposide—hematologic cancer	2.25e-05	6.82e-05	CcSEcCtD
Fenofibrate—Malnutrition—Doxorubicin—hematologic cancer	2.25e-05	6.81e-05	CcSEcCtD
Fenofibrate—Erythema—Doxorubicin—hematologic cancer	2.25e-05	6.81e-05	CcSEcCtD
Fenofibrate—Anaemia—Epirubicin—hematologic cancer	2.25e-05	6.8e-05	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.24e-05	0.000234	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	2.24e-05	0.000234	CbGpPWpGaD
Fenofibrate—Dyspepsia—Prednisone—hematologic cancer	2.24e-05	6.76e-05	CcSEcCtD
Fenofibrate—Rash—Etoposide—hematologic cancer	2.23e-05	6.76e-05	CcSEcCtD
Fenofibrate—PPARA—Metabolism—GSTM1—hematologic cancer	2.23e-05	0.000233	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—NCOR1—hematologic cancer	2.23e-05	0.000233	CbGpPWpGaD
Fenofibrate—Dermatitis—Etoposide—hematologic cancer	2.23e-05	6.75e-05	CcSEcCtD
Fenofibrate—Headache—Etoposide—hematologic cancer	2.22e-05	6.72e-05	CcSEcCtD
Fenofibrate—Flatulence—Doxorubicin—hematologic cancer	2.22e-05	6.71e-05	CcSEcCtD
Fenofibrate—Arthralgia—Methotrexate—hematologic cancer	2.21e-05	6.7e-05	CcSEcCtD
Fenofibrate—Chest pain—Methotrexate—hematologic cancer	2.21e-05	6.7e-05	CcSEcCtD
Fenofibrate—Myalgia—Methotrexate—hematologic cancer	2.21e-05	6.7e-05	CcSEcCtD
Fenofibrate—Tension—Doxorubicin—hematologic cancer	2.21e-05	6.68e-05	CcSEcCtD
Fenofibrate—Decreased appetite—Prednisone—hematologic cancer	2.21e-05	6.68e-05	CcSEcCtD
Fenofibrate—Rash—Prednisolone—hematologic cancer	2.2e-05	6.67e-05	CcSEcCtD
Fenofibrate—Dermatitis—Prednisolone—hematologic cancer	2.2e-05	6.66e-05	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.2e-05	6.65e-05	CcSEcCtD
Fenofibrate—Malaise—Epirubicin—hematologic cancer	2.19e-05	6.64e-05	CcSEcCtD
Fenofibrate—Fatigue—Prednisone—hematologic cancer	2.19e-05	6.62e-05	CcSEcCtD
Fenofibrate—Headache—Prednisolone—hematologic cancer	2.19e-05	6.62e-05	CcSEcCtD
Fenofibrate—Discomfort—Methotrexate—hematologic cancer	2.19e-05	6.62e-05	CcSEcCtD
Fenofibrate—Nervousness—Doxorubicin—hematologic cancer	2.19e-05	6.62e-05	CcSEcCtD
Fenofibrate—Vertigo—Epirubicin—hematologic cancer	2.19e-05	6.61e-05	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—NOTCH1—hematologic cancer	2.18e-05	0.000228	CbGpPWpGaD
Fenofibrate—Leukopenia—Epirubicin—hematologic cancer	2.18e-05	6.59e-05	CcSEcCtD
Fenofibrate—Back pain—Doxorubicin—hematologic cancer	2.18e-05	6.59e-05	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism—HDC—hematologic cancer	2.18e-05	0.000227	CbGpPWpGaD
Fenofibrate—Constipation—Prednisone—hematologic cancer	2.17e-05	6.57e-05	CcSEcCtD
Fenofibrate—Muscle spasms—Doxorubicin—hematologic cancer	2.16e-05	6.55e-05	CcSEcCtD
Fenofibrate—Palpitations—Epirubicin—hematologic cancer	2.15e-05	6.51e-05	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—TNF—hematologic cancer	2.14e-05	0.000223	CbGpPWpGaD
Fenofibrate—Dizziness—Triamcinolone—hematologic cancer	2.13e-05	6.43e-05	CcSEcCtD
Fenofibrate—Cough—Epirubicin—hematologic cancer	2.12e-05	6.42e-05	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—KRAS—hematologic cancer	2.12e-05	0.000221	CbGpPWpGaD
Fenofibrate—Infection—Methotrexate—hematologic cancer	2.11e-05	6.38e-05	CcSEcCtD
Fenofibrate—Nausea—Etoposide—hematologic cancer	2.1e-05	6.37e-05	CcSEcCtD
Fenofibrate—Hypertension—Epirubicin—hematologic cancer	2.1e-05	6.36e-05	CcSEcCtD
Fenofibrate—Feeling abnormal—Prednisone—hematologic cancer	2.09e-05	6.33e-05	CcSEcCtD
Fenofibrate—Asthenia—Dexamethasone—hematologic cancer	2.09e-05	6.33e-05	CcSEcCtD
Fenofibrate—Asthenia—Betamethasone—hematologic cancer	2.09e-05	6.33e-05	CcSEcCtD
Fenofibrate—Ill-defined disorder—Doxorubicin—hematologic cancer	2.09e-05	6.32e-05	CcSEcCtD
Fenofibrate—Nervous system disorder—Methotrexate—hematologic cancer	2.08e-05	6.3e-05	CcSEcCtD
Fenofibrate—Anaemia—Doxorubicin—hematologic cancer	2.08e-05	6.3e-05	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism—MTAP—hematologic cancer	2.08e-05	0.000217	CbGpPWpGaD
Fenofibrate—Thrombocytopenia—Methotrexate—hematologic cancer	2.08e-05	6.29e-05	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Prednisone—hematologic cancer	2.08e-05	6.28e-05	CcSEcCtD
Fenofibrate—Nausea—Prednisolone—hematologic cancer	2.08e-05	6.28e-05	CcSEcCtD
Fenofibrate—Chest pain—Epirubicin—hematologic cancer	2.07e-05	6.27e-05	CcSEcCtD
Fenofibrate—Myalgia—Epirubicin—hematologic cancer	2.07e-05	6.27e-05	CcSEcCtD
Fenofibrate—Arthralgia—Epirubicin—hematologic cancer	2.07e-05	6.27e-05	CcSEcCtD
Fenofibrate—Anxiety—Epirubicin—hematologic cancer	2.06e-05	6.25e-05	CcSEcCtD
Fenofibrate—Pruritus—Dexamethasone—hematologic cancer	2.06e-05	6.24e-05	CcSEcCtD
Fenofibrate—Pruritus—Betamethasone—hematologic cancer	2.06e-05	6.24e-05	CcSEcCtD
Fenofibrate—Skin disorder—Methotrexate—hematologic cancer	2.06e-05	6.24e-05	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.06e-05	6.22e-05	CcSEcCtD
Fenofibrate—Hyperhidrosis—Methotrexate—hematologic cancer	2.05e-05	6.21e-05	CcSEcCtD
Fenofibrate—Discomfort—Epirubicin—hematologic cancer	2.05e-05	6.19e-05	CcSEcCtD
Fenofibrate—Vomiting—Triamcinolone—hematologic cancer	2.04e-05	6.18e-05	CcSEcCtD
Fenofibrate—Malaise—Doxorubicin—hematologic cancer	2.03e-05	6.14e-05	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.03e-05	0.000212	CbGpPWpGaD
Fenofibrate—Rash—Triamcinolone—hematologic cancer	2.03e-05	6.13e-05	CcSEcCtD
Fenofibrate—Dry mouth—Epirubicin—hematologic cancer	2.03e-05	6.13e-05	CcSEcCtD
Fenofibrate—Dermatitis—Triamcinolone—hematologic cancer	2.02e-05	6.12e-05	CcSEcCtD
Fenofibrate—Vertigo—Doxorubicin—hematologic cancer	2.02e-05	6.12e-05	CcSEcCtD
Fenofibrate—Anorexia—Methotrexate—hematologic cancer	2.02e-05	6.12e-05	CcSEcCtD
Fenofibrate—Urticaria—Prednisone—hematologic cancer	2.02e-05	6.1e-05	CcSEcCtD
Fenofibrate—Leukopenia—Doxorubicin—hematologic cancer	2.02e-05	6.1e-05	CcSEcCtD
Fenofibrate—Headache—Triamcinolone—hematologic cancer	2.01e-05	6.09e-05	CcSEcCtD
Fenofibrate—Body temperature increased—Prednisone—hematologic cancer	2.01e-05	6.07e-05	CcSEcCtD
Fenofibrate—Abdominal pain—Prednisone—hematologic cancer	2.01e-05	6.07e-05	CcSEcCtD
Fenofibrate—Diarrhoea—Betamethasone—hematologic cancer	2e-05	6.04e-05	CcSEcCtD
Fenofibrate—Diarrhoea—Dexamethasone—hematologic cancer	2e-05	6.04e-05	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism—CDA—hematologic cancer	1.99e-05	0.000208	CbGpPWpGaD
Fenofibrate—Palpitations—Doxorubicin—hematologic cancer	1.99e-05	6.02e-05	CcSEcCtD
Fenofibrate—Oedema—Epirubicin—hematologic cancer	1.99e-05	6.01e-05	CcSEcCtD
Fenofibrate—Hypotension—Methotrexate—hematologic cancer	1.98e-05	6e-05	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—CREBBP—hematologic cancer	1.98e-05	0.000206	CbGpPWpGaD
Fenofibrate—Infection—Epirubicin—hematologic cancer	1.97e-05	5.97e-05	CcSEcCtD
Fenofibrate—PPARA—Metabolism—MTHFR—hematologic cancer	1.97e-05	0.000206	CbGpPWpGaD
Fenofibrate—Cough—Doxorubicin—hematologic cancer	1.96e-05	5.94e-05	CcSEcCtD
Fenofibrate—Nervous system disorder—Epirubicin—hematologic cancer	1.95e-05	5.89e-05	CcSEcCtD
Fenofibrate—Thrombocytopenia—Epirubicin—hematologic cancer	1.94e-05	5.88e-05	CcSEcCtD
Fenofibrate—Hypertension—Doxorubicin—hematologic cancer	1.94e-05	5.88e-05	CcSEcCtD
Fenofibrate—Tachycardia—Epirubicin—hematologic cancer	1.94e-05	5.86e-05	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.93e-05	5.85e-05	CcSEcCtD
Fenofibrate—Skin disorder—Epirubicin—hematologic cancer	1.93e-05	5.84e-05	CcSEcCtD
Fenofibrate—Dizziness—Dexamethasone—hematologic cancer	1.93e-05	5.83e-05	CcSEcCtD
Fenofibrate—Dizziness—Betamethasone—hematologic cancer	1.93e-05	5.83e-05	CcSEcCtD
Fenofibrate—Hyperhidrosis—Epirubicin—hematologic cancer	1.92e-05	5.81e-05	CcSEcCtD
Fenofibrate—Insomnia—Methotrexate—hematologic cancer	1.92e-05	5.81e-05	CcSEcCtD
Fenofibrate—Arthralgia—Doxorubicin—hematologic cancer	1.92e-05	5.8e-05	CcSEcCtD
Fenofibrate—Chest pain—Doxorubicin—hematologic cancer	1.92e-05	5.8e-05	CcSEcCtD
Fenofibrate—Myalgia—Doxorubicin—hematologic cancer	1.92e-05	5.8e-05	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism—PC—hematologic cancer	1.92e-05	0.0002	CbGpPWpGaD
Fenofibrate—Anxiety—Doxorubicin—hematologic cancer	1.91e-05	5.78e-05	CcSEcCtD
Fenofibrate—Nausea—Triamcinolone—hematologic cancer	1.91e-05	5.77e-05	CcSEcCtD
Fenofibrate—Paraesthesia—Methotrexate—hematologic cancer	1.91e-05	5.77e-05	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.9e-05	5.76e-05	CcSEcCtD
Fenofibrate—CYP3A4—Metabolism—FTCD—hematologic cancer	1.89e-05	0.000198	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PHYH—hematologic cancer	1.89e-05	0.000198	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GMPS—hematologic cancer	1.89e-05	0.000198	CbGpPWpGaD
Fenofibrate—Discomfort—Doxorubicin—hematologic cancer	1.89e-05	5.73e-05	CcSEcCtD
Fenofibrate—Anorexia—Epirubicin—hematologic cancer	1.89e-05	5.73e-05	CcSEcCtD
Fenofibrate—Dyspnoea—Methotrexate—hematologic cancer	1.89e-05	5.72e-05	CcSEcCtD
Fenofibrate—Somnolence—Methotrexate—hematologic cancer	1.89e-05	5.71e-05	CcSEcCtD
Fenofibrate—Dry mouth—Doxorubicin—hematologic cancer	1.87e-05	5.67e-05	CcSEcCtD
Fenofibrate—Hypersensitivity—Prednisone—hematologic cancer	1.87e-05	5.66e-05	CcSEcCtD
Fenofibrate—Dyspepsia—Methotrexate—hematologic cancer	1.87e-05	5.65e-05	CcSEcCtD
Fenofibrate—Hypotension—Epirubicin—hematologic cancer	1.86e-05	5.61e-05	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism—FHL2—hematologic cancer	1.85e-05	0.000194	CbGpPWpGaD
Fenofibrate—Vomiting—Betamethasone—hematologic cancer	1.85e-05	5.61e-05	CcSEcCtD
Fenofibrate—Vomiting—Dexamethasone—hematologic cancer	1.85e-05	5.61e-05	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism—SLC35B2—hematologic cancer	1.85e-05	0.000193	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GBA—hematologic cancer	1.85e-05	0.000193	CbGpPWpGaD
Fenofibrate—Decreased appetite—Methotrexate—hematologic cancer	1.84e-05	5.58e-05	CcSEcCtD
Fenofibrate—Rash—Betamethasone—hematologic cancer	1.84e-05	5.56e-05	CcSEcCtD
Fenofibrate—Rash—Dexamethasone—hematologic cancer	1.84e-05	5.56e-05	CcSEcCtD
Fenofibrate—Oedema—Doxorubicin—hematologic cancer	1.84e-05	5.56e-05	CcSEcCtD
Fenofibrate—Dermatitis—Betamethasone—hematologic cancer	1.84e-05	5.56e-05	CcSEcCtD
Fenofibrate—Dermatitis—Dexamethasone—hematologic cancer	1.84e-05	5.56e-05	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.83e-05	5.54e-05	CcSEcCtD
Fenofibrate—Fatigue—Methotrexate—hematologic cancer	1.83e-05	5.54e-05	CcSEcCtD
Fenofibrate—Headache—Betamethasone—hematologic cancer	1.83e-05	5.53e-05	CcSEcCtD
Fenofibrate—Headache—Dexamethasone—hematologic cancer	1.83e-05	5.53e-05	CcSEcCtD
Fenofibrate—Infection—Doxorubicin—hematologic cancer	1.83e-05	5.52e-05	CcSEcCtD
Fenofibrate—Asthenia—Prednisone—hematologic cancer	1.82e-05	5.51e-05	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism—AGRN—hematologic cancer	1.82e-05	0.00019	CbGpPWpGaD
Fenofibrate—Pain—Methotrexate—hematologic cancer	1.81e-05	5.49e-05	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.81e-05	5.47e-05	CcSEcCtD
Fenofibrate—Nervous system disorder—Doxorubicin—hematologic cancer	1.8e-05	5.45e-05	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—HRAS—hematologic cancer	1.8e-05	0.000188	CbGpPWpGaD
Fenofibrate—Thrombocytopenia—Doxorubicin—hematologic cancer	1.8e-05	5.44e-05	CcSEcCtD
Fenofibrate—Pruritus—Prednisone—hematologic cancer	1.8e-05	5.44e-05	CcSEcCtD
Fenofibrate—Insomnia—Epirubicin—hematologic cancer	1.8e-05	5.43e-05	CcSEcCtD
Fenofibrate—Tachycardia—Doxorubicin—hematologic cancer	1.79e-05	5.43e-05	CcSEcCtD
Fenofibrate—Skin disorder—Doxorubicin—hematologic cancer	1.78e-05	5.4e-05	CcSEcCtD
Fenofibrate—Paraesthesia—Epirubicin—hematologic cancer	1.78e-05	5.4e-05	CcSEcCtD
Fenofibrate—Hyperhidrosis—Doxorubicin—hematologic cancer	1.78e-05	5.37e-05	CcSEcCtD
Fenofibrate—Dyspnoea—Epirubicin—hematologic cancer	1.77e-05	5.36e-05	CcSEcCtD
Fenofibrate—Somnolence—Epirubicin—hematologic cancer	1.77e-05	5.34e-05	CcSEcCtD
Fenofibrate—Anorexia—Doxorubicin—hematologic cancer	1.75e-05	5.3e-05	CcSEcCtD
Fenofibrate—Feeling abnormal—Methotrexate—hematologic cancer	1.75e-05	5.29e-05	CcSEcCtD
Fenofibrate—Dyspepsia—Epirubicin—hematologic cancer	1.75e-05	5.29e-05	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.74e-05	0.000182	CbGpPWpGaD
Fenofibrate—Diarrhoea—Prednisone—hematologic cancer	1.74e-05	5.26e-05	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Methotrexate—hematologic cancer	1.74e-05	5.25e-05	CcSEcCtD
Fenofibrate—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.73e-05	0.000181	CbGpPWpGaD
Fenofibrate—Nausea—Betamethasone—hematologic cancer	1.73e-05	5.24e-05	CcSEcCtD
Fenofibrate—Nausea—Dexamethasone—hematologic cancer	1.73e-05	5.24e-05	CcSEcCtD
Fenofibrate—Decreased appetite—Epirubicin—hematologic cancer	1.73e-05	5.22e-05	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—IL6—hematologic cancer	1.72e-05	0.00018	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—IDH2—hematologic cancer	1.72e-05	0.00018	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—HMMR—hematologic cancer	1.72e-05	0.00018	CbGpPWpGaD
Fenofibrate—Hypotension—Doxorubicin—hematologic cancer	1.72e-05	5.19e-05	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.71e-05	5.19e-05	CcSEcCtD
Fenofibrate—Fatigue—Epirubicin—hematologic cancer	1.71e-05	5.18e-05	CcSEcCtD
Fenofibrate—Constipation—Epirubicin—hematologic cancer	1.7e-05	5.14e-05	CcSEcCtD
Fenofibrate—Pain—Epirubicin—hematologic cancer	1.7e-05	5.14e-05	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism—MTAP—hematologic cancer	1.69e-05	0.000177	CbGpPWpGaD
Fenofibrate—Urticaria—Methotrexate—hematologic cancer	1.69e-05	5.1e-05	CcSEcCtD
Fenofibrate—Dizziness—Prednisone—hematologic cancer	1.68e-05	5.08e-05	CcSEcCtD
Fenofibrate—Body temperature increased—Methotrexate—hematologic cancer	1.68e-05	5.08e-05	CcSEcCtD
Fenofibrate—Abdominal pain—Methotrexate—hematologic cancer	1.68e-05	5.08e-05	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.67e-05	5.07e-05	CcSEcCtD
Fenofibrate—Insomnia—Doxorubicin—hematologic cancer	1.66e-05	5.03e-05	CcSEcCtD
Fenofibrate—PPARA—Metabolism—PIK3CG—hematologic cancer	1.66e-05	0.000173	CbGpPWpGaD
Fenofibrate—Paraesthesia—Doxorubicin—hematologic cancer	1.65e-05	4.99e-05	CcSEcCtD
Fenofibrate—Dyspnoea—Doxorubicin—hematologic cancer	1.64e-05	4.96e-05	CcSEcCtD
Fenofibrate—Feeling abnormal—Epirubicin—hematologic cancer	1.64e-05	4.95e-05	CcSEcCtD
Fenofibrate—Somnolence—Doxorubicin—hematologic cancer	1.63e-05	4.94e-05	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.63e-05	0.00017	CbGpPWpGaD
Fenofibrate—Gastrointestinal pain—Epirubicin—hematologic cancer	1.62e-05	4.91e-05	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism—ARNTL—hematologic cancer	1.62e-05	0.000169	CbGpPWpGaD
Fenofibrate—Dyspepsia—Doxorubicin—hematologic cancer	1.62e-05	4.89e-05	CcSEcCtD
Fenofibrate—Vomiting—Prednisone—hematologic cancer	1.61e-05	4.88e-05	CcSEcCtD
Fenofibrate—Rash—Prednisone—hematologic cancer	1.6e-05	4.84e-05	CcSEcCtD
Fenofibrate—Dermatitis—Prednisone—hematologic cancer	1.6e-05	4.84e-05	CcSEcCtD
Fenofibrate—Decreased appetite—Doxorubicin—hematologic cancer	1.6e-05	4.83e-05	CcSEcCtD
Fenofibrate—Headache—Prednisone—hematologic cancer	1.59e-05	4.81e-05	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—AKT1—hematologic cancer	1.59e-05	0.000166	CbGpPWpGaD
Fenofibrate—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.59e-05	4.8e-05	CcSEcCtD
Fenofibrate—Fatigue—Doxorubicin—hematologic cancer	1.58e-05	4.79e-05	CcSEcCtD
Fenofibrate—Urticaria—Epirubicin—hematologic cancer	1.58e-05	4.77e-05	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism—ACP5—hematologic cancer	1.58e-05	0.000165	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CA9—hematologic cancer	1.58e-05	0.000165	CbGpPWpGaD
Fenofibrate—Pain—Doxorubicin—hematologic cancer	1.57e-05	4.75e-05	CcSEcCtD
Fenofibrate—Constipation—Doxorubicin—hematologic cancer	1.57e-05	4.75e-05	CcSEcCtD
Fenofibrate—Body temperature increased—Epirubicin—hematologic cancer	1.57e-05	4.75e-05	CcSEcCtD
Fenofibrate—Abdominal pain—Epirubicin—hematologic cancer	1.57e-05	4.75e-05	CcSEcCtD
Fenofibrate—Hypersensitivity—Methotrexate—hematologic cancer	1.56e-05	4.73e-05	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism—NCOR2—hematologic cancer	1.56e-05	0.000162	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CREBBP—hematologic cancer	1.54e-05	0.00016	CbGpPWpGaD
Fenofibrate—Asthenia—Methotrexate—hematologic cancer	1.52e-05	4.61e-05	CcSEcCtD
Fenofibrate—CYP3A4—Metabolism—ASNS—hematologic cancer	1.51e-05	0.000158	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—DCK—hematologic cancer	1.51e-05	0.000158	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.51e-05	0.000158	CbGpPWpGaD
Fenofibrate—Feeling abnormal—Doxorubicin—hematologic cancer	1.51e-05	4.58e-05	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism—FHL2—hematologic cancer	1.51e-05	0.000158	CbGpPWpGaD
Fenofibrate—Nausea—Prednisone—hematologic cancer	1.51e-05	4.56e-05	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.5e-05	4.55e-05	CcSEcCtD
Fenofibrate—Pruritus—Methotrexate—hematologic cancer	1.5e-05	4.54e-05	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism—IDH1—hematologic cancer	1.48e-05	0.000155	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—AGRN—hematologic cancer	1.48e-05	0.000155	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTO1—hematologic cancer	1.47e-05	0.000153	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—TXN—hematologic cancer	1.47e-05	0.000153	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ABCC3—hematologic cancer	1.47e-05	0.000153	CbGpPWpGaD
Fenofibrate—Hypersensitivity—Epirubicin—hematologic cancer	1.46e-05	4.43e-05	CcSEcCtD
Fenofibrate—Urticaria—Doxorubicin—hematologic cancer	1.46e-05	4.42e-05	CcSEcCtD
Fenofibrate—PPARA—Metabolism—PIK3CD—hematologic cancer	1.46e-05	0.000152	CbGpPWpGaD
Fenofibrate—Abdominal pain—Doxorubicin—hematologic cancer	1.45e-05	4.39e-05	CcSEcCtD
Fenofibrate—Body temperature increased—Doxorubicin—hematologic cancer	1.45e-05	4.39e-05	CcSEcCtD
Fenofibrate—Diarrhoea—Methotrexate—hematologic cancer	1.45e-05	4.39e-05	CcSEcCtD
Fenofibrate—PPARA—Metabolism—ALB—hematologic cancer	1.44e-05	0.00015	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—HDC—hematologic cancer	1.44e-05	0.00015	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—SPHK1—hematologic cancer	1.43e-05	0.00015	CbGpPWpGaD
Fenofibrate—Asthenia—Epirubicin—hematologic cancer	1.42e-05	4.31e-05	CcSEcCtD
Fenofibrate—Pruritus—Epirubicin—hematologic cancer	1.41e-05	4.25e-05	CcSEcCtD
Fenofibrate—Dizziness—Methotrexate—hematologic cancer	1.4e-05	4.25e-05	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism—HMMR—hematologic cancer	1.4e-05	0.000146	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—IDH2—hematologic cancer	1.4e-05	0.000146	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—UGT1A1—hematologic cancer	1.38e-05	0.000144	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PIK3R1—hematologic cancer	1.38e-05	0.000144	CbGpPWpGaD
Fenofibrate—Diarrhoea—Epirubicin—hematologic cancer	1.36e-05	4.11e-05	CcSEcCtD
Fenofibrate—Hypersensitivity—Doxorubicin—hematologic cancer	1.35e-05	4.1e-05	CcSEcCtD
Fenofibrate—Vomiting—Methotrexate—hematologic cancer	1.35e-05	4.08e-05	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism—SLC22A1—hematologic cancer	1.34e-05	0.00014	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CRABP1—hematologic cancer	1.34e-05	0.00014	CbGpPWpGaD
Fenofibrate—Rash—Methotrexate—hematologic cancer	1.34e-05	4.05e-05	CcSEcCtD
Fenofibrate—Dermatitis—Methotrexate—hematologic cancer	1.34e-05	4.04e-05	CcSEcCtD
Fenofibrate—Headache—Methotrexate—hematologic cancer	1.33e-05	4.02e-05	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.32e-05	0.000138	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ARNTL—hematologic cancer	1.32e-05	0.000138	CbGpPWpGaD
Fenofibrate—Asthenia—Doxorubicin—hematologic cancer	1.32e-05	3.99e-05	CcSEcCtD
Fenofibrate—Dizziness—Epirubicin—hematologic cancer	1.31e-05	3.97e-05	CcSEcCtD
Fenofibrate—CYP3A4—Metabolism—CDA—hematologic cancer	1.31e-05	0.000137	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ALOX5—hematologic cancer	1.31e-05	0.000136	CbGpPWpGaD
Fenofibrate—Pruritus—Doxorubicin—hematologic cancer	1.3e-05	3.93e-05	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism—CA9—hematologic cancer	1.28e-05	0.000134	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ACP5—hematologic cancer	1.28e-05	0.000134	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PIK3CB—hematologic cancer	1.27e-05	0.000133	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NCOR2—hematologic cancer	1.27e-05	0.000132	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NUP98—hematologic cancer	1.27e-05	0.000132	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PC—hematologic cancer	1.26e-05	0.000132	CbGpPWpGaD
Fenofibrate—Vomiting—Epirubicin—hematologic cancer	1.26e-05	3.82e-05	CcSEcCtD
Fenofibrate—Nausea—Methotrexate—hematologic cancer	1.26e-05	3.81e-05	CcSEcCtD
Fenofibrate—Diarrhoea—Doxorubicin—hematologic cancer	1.26e-05	3.8e-05	CcSEcCtD
Fenofibrate—Rash—Epirubicin—hematologic cancer	1.25e-05	3.79e-05	CcSEcCtD
Fenofibrate—Dermatitis—Epirubicin—hematologic cancer	1.25e-05	3.78e-05	CcSEcCtD
Fenofibrate—Headache—Epirubicin—hematologic cancer	1.24e-05	3.76e-05	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism—ADCY7—hematologic cancer	1.23e-05	0.000128	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NCOA3—hematologic cancer	1.23e-05	0.000128	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.22e-05	0.000127	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GBA—hematologic cancer	1.22e-05	0.000127	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NUP214—hematologic cancer	1.22e-05	0.000127	CbGpPWpGaD
Fenofibrate—Dizziness—Doxorubicin—hematologic cancer	1.22e-05	3.68e-05	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.21e-05	0.000126	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—IDH1—hematologic cancer	1.21e-05	0.000126	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—MAPK3—hematologic cancer	1.21e-05	0.000126	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ABCG2—hematologic cancer	1.19e-05	0.000125	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—MTR—hematologic cancer	1.19e-05	0.000125	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTO1—hematologic cancer	1.19e-05	0.000125	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ABCC3—hematologic cancer	1.19e-05	0.000125	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—TXN—hematologic cancer	1.19e-05	0.000125	CbGpPWpGaD
Fenofibrate—Nausea—Epirubicin—hematologic cancer	1.18e-05	3.57e-05	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—MYC—hematologic cancer	1.17e-05	0.000122	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ENO2—hematologic cancer	1.17e-05	0.000122	CbGpPWpGaD
Fenofibrate—Vomiting—Doxorubicin—hematologic cancer	1.17e-05	3.53e-05	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism—SPHK1—hematologic cancer	1.17e-05	0.000122	CbGpPWpGaD
Fenofibrate—Rash—Doxorubicin—hematologic cancer	1.16e-05	3.51e-05	CcSEcCtD
Fenofibrate—Dermatitis—Doxorubicin—hematologic cancer	1.16e-05	3.5e-05	CcSEcCtD
Fenofibrate—Headache—Doxorubicin—hematologic cancer	1.15e-05	3.48e-05	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism—GSTT1—hematologic cancer	1.14e-05	0.000119	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—UGT1A1—hematologic cancer	1.12e-05	0.000117	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.12e-05	0.000117	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—MTAP—hematologic cancer	1.12e-05	0.000117	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—SDC1—hematologic cancer	1.11e-05	0.000116	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PTEN—hematologic cancer	1.1e-05	0.000115	CbGpPWpGaD
Fenofibrate—Nausea—Doxorubicin—hematologic cancer	1.09e-05	3.3e-05	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism—CRABP1—hematologic cancer	1.09e-05	0.000114	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—SLC22A1—hematologic cancer	1.09e-05	0.000114	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ALOX5—hematologic cancer	1.06e-05	0.000111	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.06e-05	0.000111	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.05e-05	0.000109	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—EP300—hematologic cancer	1.05e-05	0.000109	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NUP98—hematologic cancer	1.03e-05	0.000108	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1e-05	0.000105	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ADCY7—hematologic cancer	1e-05	0.000104	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NCOA3—hematologic cancer	1e-05	0.000104	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—FHL2—hematologic cancer	9.95e-06	0.000104	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NUP214—hematologic cancer	9.93e-06	0.000104	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	9.82e-06	0.000103	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—AGRN—hematologic cancer	9.76e-06	0.000102	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ABCG2—hematologic cancer	9.72e-06	0.000102	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—MTR—hematologic cancer	9.72e-06	0.000102	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ENO2—hematologic cancer	9.54e-06	9.96e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NQO1—hematologic cancer	9.44e-06	9.86e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CD44—hematologic cancer	9.44e-06	9.86e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—HMMR—hematologic cancer	9.25e-06	9.66e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—IDH2—hematologic cancer	9.25e-06	9.66e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTT1—hematologic cancer	9.25e-06	9.66e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	9.25e-06	9.66e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	9.11e-06	9.51e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—SDC1—hematologic cancer	9.04e-06	9.44e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYCS—hematologic cancer	8.94e-06	9.33e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	8.88e-06	9.27e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ARNTL—hematologic cancer	8.7e-06	9.08e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	8.64e-06	9.02e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	8.52e-06	8.9e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CA9—hematologic cancer	8.46e-06	8.84e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ACP5—hematologic cancer	8.46e-06	8.84e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NCOR2—hematologic cancer	8.35e-06	8.72e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	8.15e-06	8.51e-05	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—AKT1—hematologic cancer	8.13e-06	8.49e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.99e-06	8.34e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—IDH1—hematologic cancer	7.96e-06	8.31e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTP1—hematologic cancer	7.88e-06	8.23e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ABCC3—hematologic cancer	7.87e-06	8.21e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—TXN—hematologic cancer	7.87e-06	8.21e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTO1—hematologic cancer	7.87e-06	8.21e-05	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PIK3CA—hematologic cancer	7.74e-06	8.09e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SPHK1—hematologic cancer	7.7e-06	8.04e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CD44—hematologic cancer	7.69e-06	8.03e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NQO1—hematologic cancer	7.69e-06	8.03e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.62e-06	7.96e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.53e-06	7.86e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ABCB1—hematologic cancer	7.46e-06	7.79e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—UGT1A1—hematologic cancer	7.4e-06	7.72e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYCS—hematologic cancer	7.27e-06	7.6e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NCOR1—hematologic cancer	7.24e-06	7.56e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTM1—hematologic cancer	7.24e-06	7.56e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	7.23e-06	7.55e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CRABP1—hematologic cancer	7.2e-06	7.51e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SLC22A1—hematologic cancer	7.2e-06	7.51e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ALOX5—hematologic cancer	7.01e-06	7.32e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NUP98—hematologic cancer	6.79e-06	7.09e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.59e-06	6.88e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.59e-06	6.88e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NUP214—hematologic cancer	6.55e-06	6.84e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.5e-06	6.79e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—MTR—hematologic cancer	6.41e-06	6.7e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ABCG2—hematologic cancer	6.41e-06	6.7e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTP1—hematologic cancer	6.41e-06	6.69e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—MTHFR—hematologic cancer	6.4e-06	6.68e-05	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—AKT1—hematologic cancer	6.33e-06	6.6e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ENO2—hematologic cancer	6.29e-06	6.57e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.2e-06	6.48e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTT1—hematologic cancer	6.1e-06	6.37e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ABCB1—hematologic cancer	6.07e-06	6.34e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SDC1—hematologic cancer	5.96e-06	6.23e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTM1—hematologic cancer	5.89e-06	6.15e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NCOR1—hematologic cancer	5.89e-06	6.15e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.64e-06	5.89e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PIK3CG—hematologic cancer	5.38e-06	5.61e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—MTHFR—hematologic cancer	5.21e-06	5.44e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NQO1—hematologic cancer	5.07e-06	5.29e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CD44—hematologic cancer	5.07e-06	5.29e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CREBBP—hematologic cancer	4.98e-06	5.2e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYCS—hematologic cancer	4.8e-06	5.01e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.77e-06	4.98e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PIK3CD—hematologic cancer	4.73e-06	4.93e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ALB—hematologic cancer	4.66e-06	4.87e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.59e-06	4.79e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PIK3R1—hematologic cancer	4.46e-06	4.66e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PIK3CG—hematologic cancer	4.37e-06	4.57e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.23e-06	4.42e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PIK3CB—hematologic cancer	4.12e-06	4.3e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CREBBP—hematologic cancer	4.06e-06	4.24e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ABCB1—hematologic cancer	4e-06	4.18e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.89e-06	4.06e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.89e-06	4.06e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PIK3CD—hematologic cancer	3.85e-06	4.02e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ALB—hematologic cancer	3.8e-06	3.96e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PIK3R1—hematologic cancer	3.63e-06	3.79e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PTEN—hematologic cancer	3.56e-06	3.72e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.43e-06	3.59e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—EP300—hematologic cancer	3.39e-06	3.54e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PIK3CB—hematologic cancer	3.35e-06	3.5e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PTEN—hematologic cancer	2.9e-06	3.02e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.89e-06	3.01e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—EP300—hematologic cancer	2.76e-06	2.88e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.68e-06	2.79e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.54e-06	2.65e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PIK3CA—hematologic cancer	2.51e-06	2.62e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ALB—hematologic cancer	2.5e-06	2.61e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.4e-06	2.5e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.21e-06	2.31e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—AKT1—hematologic cancer	2.05e-06	2.14e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.04e-06	2.13e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PTEN—hematologic cancer	1.91e-06	1.99e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—EP300—hematologic cancer	1.82e-06	1.9e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—AKT1—hematologic cancer	1.67e-06	1.74e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.35e-06	1.41e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—AKT1—hematologic cancer	1.1e-06	1.15e-05	CbGpPWpGaD
